When health officials set up a monkeypox vaccination clinic at a major LGBTQIA+ festival in Louisiana, they wanted to know who was showing up for the shot. This report describes the characteristics of the people who received the JYNNEOS vaccine before and during the festival. It's important to note that this is not a clinical trial. The report doesn't tell us how well the vaccine worked at preventing infection, what side effects people experienced, or how many people were vaccinated. It simply gives a snapshot of who was getting vaccinated in that specific place and time. Without details on the number of people or their specific outcomes, this information is best seen as a starting point for understanding vaccination efforts in community settings.
JYNNEOS vaccine recipients characterized at Louisiana LGBTQIA+ festivalWho got the monkeypox vaccine at a major LGBTQIA+ festival in Louisiana?
AI-generated summary of the cited source, checked by automated accuracy review. How we work
Key Takeaway
Note: This report provides no clinical evidence on JYNNEOS vaccine outcomes.
A report described characteristics of JYNNEOS vaccine recipients before and during a large multiday LGBTQIA+ festival in Louisiana. The publication type was a report, not a formal study. The population consisted of vaccine recipients at this specific event, but the sample size was not reported. No comparator group was identified.
No main results were reported. The report did not provide any outcome data, effect sizes, absolute numbers, or statistical measures. No primary or secondary outcomes were specified. The follow-up duration was not reported.
Safety and tolerability data were not reported. No information on adverse events, serious adverse events, or discontinuations was provided. The funding sources and potential conflicts of interest were not reported. Key limitations include the absence of study results, outcomes, and safety information. This report offers only a descriptive account without evidence to guide clinical practice regarding JYNNEOS vaccination.
What this means for you:
A report describes who got the monkeypox vaccine at a Louisiana festival, but doesn't measure its effects. More on Mpox
LC16m8 pre-exposure prophylaxis showed no mpox cases in a randomized controlled trial of high-risk adults
Mpox Vaccine Shows Promise for High-Risk Groups, But Key Questions Remain
This randomized controlled trial enrolled 570 participants in an early-vaccination group and 565 in a late-vaccination group. No mpox cases …
A new mpox vaccine produced strong immune responses in high-risk individuals, including those with HIV, but researchers still can't say for …
Technical report validates AI tool for classifying MPXV subclades using genomic data
New AI tool quickly identifies dangerous mpox virus types from DNA samples
This technical report describes a methodological development for a software tool called CladePredictor-MPXV.
This new AI tool sorts mpox virus types in seconds and helps doctors track dangerous outbreaks faster than ever before
EBOV-specific gene signature identified in nonhuman primates and human cohorts with Ebola infection
New gene signature can spot Ebola infection in blood samples
This observational cohort study analyzed RNA-Seq data from nonhuman primates and human cohorts with Ebola virus infection and comparator inf…
Researchers found a 50-gene signature that reliably separates Ebola from other infections in blood tests, pointing to a future diagnostic to…
Review of genomic surveillance finds concurrent Mpox subclade circulation across Africa
Mpox Is Spreading in Ways Scientists Didn't See Coming
This review synthesizes genomic surveillance data from 24 African Union Member States, covering 3,450 high-quality MPXV virus whole genomes.
Mpox is spreading across Africa in surprising ways, with different strains jumping from animals to people or spreading quietly between human…
View Original Abstract ↓
This report describes a large monkeypox vaccination event at an LGBTQIA+ festival in Louisiana.
Intrawound tobramycin plus vancomycin did not reduce deep infection risk compared with vancomycin alone in high-risk tibial fractures
Adding Antibiotics to Bone Surgery Didn't Lower Infection Risk
Related in Infectious Disease
FDA Approves Linezolid Injection for Gram-Positive Infections Including Pneumonia and Skin Infections
FDA approves new antibiotic injection for serious bacterial infections
The FDA approved linezolid injection for nosocomial pneumonia, community-acquired pneumonia, complicated skin infections, and vancomycin-res…
The FDA approved linezolid injection for treating serious infections like pneumonia and skin infections caused by certain bacteria, includin…
Intrawound vancomycin powder reduces postoperative infection risk (OR 0.59) in high-risk fracture fixation cases
Vancomycin Powder May Reduce Infections After High Risk Fractures
This meta-analysis of 3185 patients found that intrawound vancomycin powder significantly reduced postoperative infection rates (OR 0.59; 95…
A review of data suggests that using vancomycin powder in wounds may lower infection rates for patients with serious bone fractures.
Risk-adapted HLA delisting and imlifidase enable deceased-donor kidney transplantation for highly sensitized candidates
New guide helps transplant kidneys for hardest-to-match patients
This expert consensus provides a practical guideline for managing highly sensitized adult patients on the waitlist for deceased-donor kidney…
A new expert guide shows how to safely transplant kidneys into highly sensitized patients who have few options left.
Regenerative endodontic procedures may lead to unusual root morphology in immature teeth
Regenerative procedures can lead to unusual tooth root growth
This case report with literature review describes 2 immature teeth with pulp necrosis secondary to dens evaginatus treated with regenerative…
A new look at dental treatments shows that while some procedures save teeth, they can sometimes cause unexpected changes in how roots grow.
From Other Specialties
Post-extubation dysphagia incidence ranges from 28.36% to 68.94% in critically ill children
High rates of swallowing problems found in children after intubation
This scoping review of 15 studies examines the incidence and predictors of pediatric post-extubation dysphagia (PED). The authors identify h…
Many critically ill children struggle to swallow safely after breathing tubes are removed, with some studies showing issues in up to 69% of …
Circular RNAs may regulate ferroptosis and anti-tumor immunity in cancer via multiple mechanisms
Circular RNAs may offer new ways to target cancer cells
This systematic review explores how circular RNAs (circRNAs) act as molecular bridges to simultaneously regulate ferroptosis and anti-tumor …
New research identifies circular RNAs as molecular bridges that could help doctors diagnose and treat cancer more precisely.
Meningeal Immune System Offers New Target for Glioblastoma Immunotherapy
New approach targets the immune system to treat brain tumors
This systematic review explores how targeting the meningeal immune system, including dural lymphatics and rBAMs, could overcome current barr…
A new strategy focuses on the area where brain tumors meet the body's defenses to improve how immunotherapy works for glioblastoma.
A 6 dimension and 42 item system provides early risk assessment for high-risk diabetic feet
Experts Develop New Risk Assessment System for Diabetic Feet
This expert consultation and guideline describes the development of an early risk assessment system for high-risk diabetic feet. The consens…
A new assessment system identifies risk factors like nerve damage and circulation to help manage and prevent complications in patients with …